{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:46:12Z","timestamp":1785267972738,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sygesikringen \u201cdanmark\u201d, Sundhedsdonationer","award":["2022-0020"],"award-info":[{"award-number":["2022-0020"]}]},{"name":"Region of Southern Denmark\u2019s Fund for Free and Strategic Research","award":["2024-0027"],"award-info":[{"award-number":["2024-0027"]}]},{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic back pain remains a leading cause of disability worldwide, with high societal and healthcare costs and limited effective treatment options. More than 50% of people with chronic back pain also report insomnia symptoms. Melatonin, primarily known for its use in treating insomnia and jetlag, has shown promising effects as a pain medication in chronic non-musculoskeletal pain conditions. We aim to determine the efficacy of 6\u00a0weeks of melatonin compared with placebo in reducing average pain intensity in patients with chronic disabling back pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The Melatonin for Chronic Back Pain (MOCHA) trial is a 1:1 randomized, placebo-controlled, double-blind, superiority trial including 220 patients with chronic disabling back pain randomized to either 10\u00a0mg (given as two 5\u00a0mg tablets) melatonin daily for 6\u00a0weeks or an identically looking placebo tablet. The primary outcome is the between-group difference in change in average pain intensity during the last 7\u00a0days from baseline to 6\u00a0weeks. Secondary outcomes include insomnia severity, back pain-related disability, global perceived effect, physical and mental health, and pain sensitivity. Exploratory outcomes are physiological sleep metrics assessed with ear electroencephalography (EEG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This trial evaluates the efficacy of melatonin, an inexpensive and widely available intervention that could potentially reduce pain and sleep problems in a population with few effective treatment options available.<\/jats:p>\n                    <jats:p>Trial registration<\/jats:p>\n                    <jats:p>CTIS EU-CT 2023-503530-41-00. Registered on March 4th, 2024.<\/jats:p>\n                    <jats:p>ClinicalTrials.gov NCT06476392. Registered on June 20th, 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09206-w","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:28:19Z","timestamp":1763404099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Melatonin for chronic back pain (the MOCHA trial): study protocol for a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9445-8632","authenticated-orcid":false,"given":"K\u00fcbra","family":"Kilic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Bjarke","family":"V\u00e6gter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Due","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Vach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hartvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Willem","family":"Koes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preben","family":"Kidmose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Bloch","family":"Thorlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"6","key":"9206_CR1","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","volume":"5","author":"ML Ferreira","year":"2023","unstructured":"Ferreira ML, De Luca K, Haile LM, Steinmetz JD, Culbreth GT, Cross M, et al. Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316\u201329.","journal-title":"Lancet Rheumatol"},{"key":"9206_CR2","doi-asserted-by":"publisher","unstructured":"The Lancet Rheumatology. The global epidemic of low back pain. Lancet Rheumatol. 2023;5(6):e305. Available from: https:\/\/doi.org\/10.1016\/S2665-9913(23)00133-9","DOI":"10.1016\/S2665-9913(23)00133-9"},{"key":"9206_CR3","doi-asserted-by":"publisher","unstructured":"Vardeh D, Mannion RJ, Woolf CJ. Toward a Mechanism-Based Approach to Pain Diagnosis. J Pain. 2016;17(9 Suppl):T50\u201369. https:\/\/doi.org\/10.1016\/j.jpain.2016.03.001.","DOI":"10.1016\/j.jpain.2016.03.001"},{"issue":"2","key":"9206_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12445-017-0048-1","volume":"60","author":"W Enthoven","year":"2017","unstructured":"Enthoven W. Paracetamol for low back pain. Huisarts Wet. 2017;60(2):96.","journal-title":"Huisarts Wet"},{"key":"9206_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6380","author":"RA Deyo","year":"2015","unstructured":"Deyo RA, Von Korff M, Duhrkoop D, BMJ Publishing Group. Opioids for low back pain. BMJ. 2015. https:\/\/doi.org\/10.1136\/bmj.g6380.","journal-title":"BMJ"},{"key":"9206_CR6","doi-asserted-by":"publisher","unstructured":"Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2(2):CD012087. https:\/\/doi.org\/10.1002\/14651858.CD012087.","DOI":"10.1002\/14651858.CD012087"},{"key":"9206_CR7","doi-asserted-by":"crossref","unstructured":"Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016;(6):CD012230.","DOI":"10.1002\/14651858.CD012230"},{"key":"9206_CR8","unstructured":"WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"9206_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2869.2007.00571.x","volume":"16","author":"NKY Tang","year":"2007","unstructured":"Tang NKY, Wright KJ, Salkovskis PM. Prevalence and correlates of clinical insomnia co-occurring with chronic back pain. J Sleep Res. 2007;16(1):85\u201395.","journal-title":"J Sleep Res"},{"key":"9206_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1087-0792(03)00044-3","volume":"8","author":"MT Smith","year":"2004","unstructured":"Smith MT, Haythornthwaite JA, W.B. Saunders Ltd. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004;8:119\u201332.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"9206_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pain.2008.01.025","volume":"137","author":"RR Edwards","year":"2008","unstructured":"Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain. 2008;137(1):202\u20137.","journal-title":"Pain"},{"key":"9206_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.smrv.2017.08.001","volume":"39","author":"EF Afolalu","year":"2018","unstructured":"Afolalu EF, Ramlee F, Tang NKY, W.B. Saunders Ltd. Effects of sleep changes on pain-related health outcomes in the general population: a systematic review of longitudinal studies with exploratory meta-analysis. Sleep Med Rev. 2018;39:82\u201397.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"9206_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/01616412.2017.1315864","volume":"39","author":"Z Xie","year":"2017","unstructured":"Xie Z, Chen F, Li WA, Geng X, Li C, Meng X, et al. A review of sleep disorders and melatonin. Neurol Res. 2017;39(6):559\u201365. https:\/\/doi.org\/10.1080\/01616412.2017.1315864.","journal-title":"Neurol Res"},{"issue":"68","key":"9206_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2019.02.017","volume":"1","author":"S Wei","year":"2020","unstructured":"Wei S, Smits MG, Tang X, Kuang L, Meng H, Ni S, et al. Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials. Sleep Med. 2020Apr;1(68):1\u20138.","journal-title":"Sleep Med"},{"key":"9206_CR15","doi-asserted-by":"publisher","unstructured":"Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. https:\/\/doi.org\/10.1002\/14651858.CD001520.","DOI":"10.1002\/14651858.CD001520"},{"issue":"12","key":"9206_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s40263-019-00680-w","volume":"33","author":"FMC Besag","year":"2019","unstructured":"Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs. 2019;33(12):1167\u201386.","journal-title":"CNS Drugs"},{"issue":"76","key":"9206_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.sleep.2020.10.018","volume":"1","author":"H Xu","year":"2020","unstructured":"Xu H, Zhang C, Qian Y, Zou J, Li X, Liu Y, et al. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. Sleep Med. 2020Dec;1(76):113\u20139.","journal-title":"Sleep Med"},{"key":"9206_CR18","doi-asserted-by":"publisher","unstructured":"Oh SN, Myung SK, Jho HJ. Analgesic Efficacy of Melatonin: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled\u00a0Trials. J Clin Med. 2020;9(5):1553. https:\/\/doi.org\/10.3390\/jcm9051553.","DOI":"10.3390\/jcm9051553"},{"issue":"1","key":"9206_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001061","volume":"8","author":"E Andersson","year":"2023","unstructured":"Andersson E, Kander T, Werner MU, Cho JH, Kosek E, Bjurstr\u00f6m MF. Analgesic efficacy of sleep-promoting pharmacotherapy in patients with chronic pain: a systematic review and meta-analysis. Pain Rep. 2023;8(1):e1061.","journal-title":"Pain Rep"},{"key":"9206_CR20","doi-asserted-by":"crossref","unstructured":"Zhu C, Xu Y, Duan Y, Li W, Zhang L, Huang Y, et al. Exogenous melatonin in the treatment of pain: a systematic review and meta-analysis. Vol. 8, Oncotarget. 2017. Available from: www.impactjournals.com\/oncotarget\/","DOI":"10.18632\/oncotarget.21504"},{"issue":"1","key":"9206_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-016-0049-y","volume":"5","author":"A Danilov","year":"2016","unstructured":"Danilov A, Kurganova J. Melatonin in chronic pain syndromes. Pain Ther. 2016;5(1):1\u201317.","journal-title":"Pain Ther"},{"key":"9206_CR22","doi-asserted-by":"crossref","unstructured":"Tang Q, Huang Y, Zhu L, Zhang W, Zhao Y, Zhong Y. The Effect of Melatonin on Radicular Pain in a Rat Model of Lumbar Disc Herniation. Spine (Phila Pa 1976). 2022;47(10). Available from: https:\/\/journals.lww.com\/spinejournal\/fulltext\/2022\/05150\/the_effect_of_melatonin_on_radicular_pain_in_a_rat.10.aspx","DOI":"10.1097\/BRS.0000000000004329"},{"key":"9206_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-40","volume":"15","author":"SA de Zanette","year":"2014","unstructured":"de Zanette SA, Vercelino R, Laste G, Rozisky JR, Schwertner A, Machado CB, et al. Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. BMC Pharmacol Toxicol. 2014;15:40.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"9206_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1099800418811634","volume":"21","author":"MY Casta\u00f1o","year":"2019","unstructured":"Casta\u00f1o MY, Garrido M, Rodr\u00edguez AB, G\u00f3mez M\u00c1. Melatonin Improves Mood Status and Quality of Life and Decreases Cortisol Levels in Fibromyalgia. Biol Res Nurs. 2019Jan 1;21(1):22\u20139.","journal-title":"Biol Res Nurs"},{"issue":"3","key":"9206_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1600-079X.2010.00836.x","volume":"50","author":"SAR Hussain","year":"2011","unstructured":"Hussain SAR, Al-Khalifa II, Jasim NA, Gorial FI. Adjuvant use of melatonin for treatment of fibromyalgia. J Pineal Res. 2011;50(3):267\u201371.","journal-title":"J Pineal Res"},{"issue":"3","key":"9206_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/j.pain.0000000000001758","volume":"161","author":"M Von Korff","year":"2020","unstructured":"Von Korff M, DeBar LL, Krebs EE, Kerns RD, Deyo RA, Keefe FJ. Graded chronic pain scale revised: mild, bothersome, and high-impact chronic pain. Pain. 2020;161(3):651\u201361.","journal-title":"Pain"},{"key":"9206_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-200012150-00006","author":"M Roland","year":"2000","unstructured":"Roland M, Fairbank J. The Roland-Morris disability questionnaire and the Oswestry disability questionnaire. Spine. 2000. https:\/\/doi.org\/10.1097\/00007632-200012150-00006.","journal-title":"Spine"},{"key":"9206_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-00234-5","author":"C Burbridge","year":"2020","unstructured":"Burbridge C, Randall JA, Abraham L, Bush EN. Measuring the impact of chronic low back pain on everyday functioning: content validity of the Roland Morris disability questionnaire. J Patient Rep Outcomes. 2020. https:\/\/doi.org\/10.1186\/s41687-020-00234-5.","journal-title":"J Patient Rep Outcomes"},{"key":"9206_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-7-82","author":"HH Lauridsen","year":"2006","unstructured":"Lauridsen HH, Hartvigsen J, Manniche C, Korsholm L, Grunnet-Nilsson N. Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musculoskelet Disord. 2006. https:\/\/doi.org\/10.1186\/1471-2474-7-82.","journal-title":"BMC Musculoskelet Disord"},{"key":"9206_CR30","unstructured":"Albert HB, Jensen AM, Dahl D, Rasmussen MN. Kriterievalidering af Roland Morris-sp\u00f8rgeskemaet. Et oversat internationalt skema til vurdering af aendringer i funktionsniveau hos patienter med laendesmerter og iskias [Criteria validation of the Roland Morris questionnaire. A Danish translation of the international scale for the assessment of functional level in patients with low back pain and sciatica]. Danish. Ugeskr Laeger. 2003;165(18):1875\u201380.\u00a0Danish."},{"key":"9206_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.09.009","author":"SJ Kamper","year":"2010","unstructured":"Kamper SJ, Ostelo RWJG, Knol DL, Maher CG, de Vet HCW, Hancock MJ. Global perceived effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. J Clin Epidemiol. 2010. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.09.009.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"9206_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-0182-6","volume":"4","author":"KB Dieperink","year":"2020","unstructured":"Dieperink KB, Elnegaard CM, Winther B, Lohman A, Zerlang I, M\u00f6ller S, et al. Preliminary validation of the insomnia severity index in Danish outpatients with a medical condition. J Patient Rep Outcomes. 2020;4(1):18.","journal-title":"J Patient Rep Outcomes"},{"key":"9206_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.5.601","author":"CM Morin","year":"2011","unstructured":"Morin CM, Belleville G, B\u00e9langer L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011. https:\/\/doi.org\/10.1093\/sleep\/34.5.601.","journal-title":"Sleep"},{"key":"9206_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.011","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol. 2010. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.011.","journal-title":"J Clin Epidemiol"},{"key":"9206_CR35","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000002396","author":"BH Vaegter","year":"2020","unstructured":"Vaegter BH, Thinggaard P, Madsen CH\u00f8, Hasenbring M, Thorlund JB. Power of words: influence of preexercise information on hypoalgesia after exercise - randomized controlled trial. Med Sci Sports Exerc. 2020. https:\/\/doi.org\/10.1249\/MSS.0000000000002396.","journal-title":"Med Sci Sports Exerc"},{"key":"9206_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000294","author":"T Graven-Nielsen","year":"2015","unstructured":"Graven-Nielsen T, Vaegter HB, Finocchietti S, Handberg G, Arendt-Nielsen L. Assessment of musculoskeletal pain sensitivity and temporal summation by cuff pressure algometry: a reliability study. Pain. 2015. https:\/\/doi.org\/10.1097\/j.pain.0000000000000294.","journal-title":"Pain"},{"key":"9206_CR37","doi-asserted-by":"publisher","unstructured":"Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, Troester MT, Vaughn BV. AASM Scoring Manual Updates for 2017 (Version 2.4). J Clin Sleep Med. 2017;13(5):665-6. https:\/\/doi.org\/10.5664\/jcsm.6576.","DOI":"10.5664\/jcsm.6576"},{"key":"9206_CR38","doi-asserted-by":"publisher","unstructured":"van der Gaag WH, Roelofs PD, Enthoven WT, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for acute low back pain. Cochrane Database Syst Rev. 2020;4(4):CD013581. https:\/\/doi.org\/10.1002\/14651858.CD013581.","DOI":"10.1002\/14651858.CD013581"},{"issue":"11","key":"9206_CR39","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","volume":"11","author":"R Buynak","year":"2010","unstructured":"Buynak R, Shapiro DY, Okamoto A, Hove IV, Rauschkolb C, Steup A, et al. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled phase III study. Expert Opin Pharmacother. 2010;11(11):1787\u2013804.","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"9206_CR40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/pme.12377","volume":"15","author":"RL Rauck","year":"2014","unstructured":"Rauck RL, Nalamachu S, Wild JE, Walker GS, Robinson CY, Davis CS, et al. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study. Pain Med. 2014;15(6):975\u201385.","journal-title":"Pain Med"},{"key":"9206_CR41","doi-asserted-by":"crossref","unstructured":"Leacy FP, Floyd S, Yates TA, White IR. Analyses of sensitivity to the missing-at-random assumption using multiple imputation with delta adjustment: Application to a tuberculosis\/HIV prevalence survey with incomplete HIV-status data. Vol. 185, American Journal of Epidemiology. Oxford University Press; 2017. p. 304\u201315.","DOI":"10.1093\/aje\/kww107"},{"issue":"15","key":"9206_CR42","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/sim.7643","volume":"37","author":"DM Tompsett","year":"2018","unstructured":"Tompsett DM, Leacy F, Moreno-Betancur M, Heron J, White IR. On the use of the not-at-random fully conditional specification (NARFCS) procedure in practice. Stat Med. 2018Jul 10;37(15):2338\u201353.","journal-title":"Stat Med"},{"issue":"21","key":"9206_CR43","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/sim.8569","volume":"39","author":"S Cro","year":"2020","unstructured":"Cro S, Morris TP, Kenward MG, Carpenter JR. Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide. Stat Med. 2020Sep 20;39(21):2815\u201342.","journal-title":"Stat Med"},{"issue":"3","key":"9206_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","volume":"36","author":"LPH Andersen","year":"2016","unstructured":"Andersen LPH, G\u00f6genur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016;36(3):169\u201375.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"9206_CR45","first-page":"1","volume":"72","author":"Z MenczelSchrire","year":"2022","unstructured":"MenczelSchrire Z, Phillips CL, Chapman JL, Duffy SL, Wong G, D\u2019Rozario AL, et al. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. J Pineal Res. 2022;72(2):1\u201321.","journal-title":"J Pineal Res"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09206-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T07:02:32Z","timestamp":1763449352000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9206"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09206-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6753629\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Danish National Center for Ethics approved the study, and data processing in connection with the study has been reported to the region of Southern Denmark\u2019s list of on-going research projects via the Executive Secretariat at Odense University Hospital. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"The consent forms will be made available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"513"}}